DeHeng Advised 10K Genomics on its Tens

of Millions RMB Pre-A round Financing

2021-02-07

10K Genomics, a company specialized on developing high-throughput single-cell sequencing solutions, recently announced the completion of its Pre-A round financing which is invested solely by Northern Light Venture Capital.

DeHeng acted as the legal counsel for this project, and formed a project team with Zhang Lei, Fang Wen, and Sun Kai as the main members, representing Northern Light Venture Capital to participate in the legal due diligence, transaction documents drafting, project negotiation, and coordinate other investors and old shareholders to smoothly advance this project. The lawyers of the project team worked closely to complete the work of this project professionally and efficiently, and won the trust of customers and the company. Relying on years of accumulated rich project experience, industry resources, and rapid and in-depth professional research and services ability, the lawyers of project team are deeply engaged in professional legal services in new economic fields such as medicine, medical health, artificial intelligence, big data, TMT, cutting-edge manufacturing, etc., and will continue to provide high-level legal services to more clients.